Kasuga, Japan

Akira Yagi

This inventor holds 1 USPTO granted patent. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Yagi. Retrieved from https://idiyas.com/inventor/akira-yagi-hdkplcn9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Yagi: Innovator in Pharmaceutical Chemistry

Introduction

Akira Yagi is a notable inventor based in Kasuya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on alkyl-ketohexopyranoside derivatives.

Latest Patents

Yagi holds a patent for "Alkyl-ketohexopyranoside derivatives and method of use." This patent describes an alkyl-ketohexopyranoside derivative that exhibits pharmacological actions, including antiallergic effects. The derivative is represented by a specific general formula, wherein R is an alkyl group containing at least three carbon atoms. Notably, the derivatives exclude the D-fructose derivative, particularly when R is an n-propyl group. He has 1 patent to his name.

Career Highlights

Akira Yagi is associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, particularly in allergy treatment.

Collaborations

Yagi has collaborated with notable colleagues, including Kanji Noda and Akira Nakagawa, who contribute to his research endeavors.

Conclusion

Akira Yagi's innovative work in pharmaceutical chemistry, particularly with alkyl-ketohexopyranoside derivatives, showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest for effective treatments in allergy management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…